At least sev­en drug­mak­ers say they will par­tic­i­pate in round two of IRA ne­go­ti­a­tions 

More than half of drug­mak­ers have agreed to par­tic­i­pate in the sec­ond round of Medicare price ne­go­ti­a­tions amid on­go­ing le­gal bat­tles and un­cer­tain­ty sur­round­ing the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.